Tang, X., Yang, L., Li, Z., Nalin, A. P., Dai, H., Xu, T., . . . Yu, J. (2018). First-in-man clinical trial of CAR NK-92 cells: Safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Am J Cancer Res.
استشهاد بنمط شيكاغوTang, Xiaowen, et al. "First-in-man Clinical Trial of CAR NK-92 Cells: Safety Test of CD33-CAR NK-92 Cells in Patients With Relapsed and Refractory Acute Myeloid Leukemia." Am J Cancer Res 2018.
MLA استشهادTang, Xiaowen, et al. "First-in-man Clinical Trial of CAR NK-92 Cells: Safety Test of CD33-CAR NK-92 Cells in Patients With Relapsed and Refractory Acute Myeloid Leukemia." Am J Cancer Res 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.